Annual Review of Psychology
August 2, 2024
Keith Humphreys, Daniel Stjepanović, Wayne Hall et al.
18 citations
Therapeutic claims about many psychedelic drugs have not been evaluated in any studies of even modest rigor. The science of psychedelic drugs is strengthening, however, making it easier to differentiate some promising findings amid the hype that suffuses this research area. Ketamine has risks of adverse side effects (e.g., addiction and cystitis), but multiple studies suggest it can benefit...
Journal of Clinical Psychology
August 1, 2024
William K Macnulty, Jay M Uomoto, Seattle M Peterson
3 citations
The primary aim of this study was to conduct an open pilot clinical trial of a brief mindfulness-based intervention for persistent postconcussion symptoms that occur after mild traumatic brain injury in military service members. For many service members, operational tempo and other time constraints may prevent them from completing a standard mindfulness-based stress reduction course. Thus, this...
Archives of Toxicology
August 1, 2024
Brian A Baldo
5 citations
The phenylethylamine, 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'), is the prototypical example of an entactogen. Its original placement in highly restrictive drug usage categories in the US and UK, led to an inevitable restriction on MDMA neuroscience research and treatment. The dominant pharmacological effects of MDMA are its properties of release and inhibition of reuptake of amine...
July 25, 2024
Anggraeni Endah Kusumaningrum, Ardianto Sucinta
In recent years, interest in the use of psychedelic substances in the treatment of mental disorders has increased significantly. Recent research shows the potential of psychedelic substances such as psilocybin, LSD, and MDMA to treat disorders such as major depression, post-traumatic stress disorder (PTSD), and substance addiction. However, the clinical use of psychedelic substances remains...
British Journal of Clinical Pharmacology
July 24, 2024
Eric L Garland
The opioid crisis emerged in part due to the overprescribing of opioid analgesics for chronic pain. Although not the only source of the current epidemic of opioid use disorder (OUD), the prescription of opioids for chronic pain remains one vector for the development of opioid misuse and OUD. However, opioid tapering is not appropriate for all patients, and some patients may need to remain on...
Psychoactives
July 18, 2024
Isaac Burt
Psychedelics, combined with talk therapy, indicate promise with challenging clients, such as those struggling with PTSD. Furthermore, groupwork, with the emphasis on social connections, can be an effective modality. There appears, however, little movement with integrating psychedelics with professional counseling and even less in groupwork. Societal perceptions of psychedelics and the concern...
Research Square
July 15, 2024
Cynthia U Price, Kenneth C Pike, Anna Treadway et al.
preprint
While effective, medication for opioid use disorder (MOUD) treatment outcomes can be limited by co-occurring polysubstance use, mental health and chronic pain conditions. Interoceptive training may facilitate well-being and support medication treatment for MOUD. This study examined the pre-post effects of the mindfulness-based intervention Mindful Awareness in Body-oriented Therapy (MABT) as an...
Psychopharmacology Bulletin
July 8, 2024
Justin Faden, Leslie Citrome
29 citations
Since the last edition of the Black Book, several innovative agents have been approved or are poised to be approved in the coming year. These include novel antidepressants, the first muscarine agonist for the treatment of schizophrenia, the first psychedelic which may be approved for the treatment of PTSD (Post Traumatic Stress Disorder), and the first disease modifying drug for the treatment...
Military psychology : the official journal of the Division of Military Psychology, American Psychological Association
July 3, 2024
Ryan G. Erbe, Peter Meindl, Elise M. Dykhuis et al.
Military members face emotion-regulation challenges due to the high-pressure nature of the profession as evidenced by rates of mental health issues within military populations. Identifying behaviors that are efficient and effective at promoting emotion-regulation and helping military members adopt them is essential. Recently, meditation has been shown to reduce stress, enhance attention control...
JAMA Psychiatry
July 1, 2024
Importance: Although grief-focused cognitive behavior therapies are the most empirically supported treatment for prolonged grief disorder, many people find this treatment difficult. A viable alternative for treatment is mindfulness-based cognitive therapy. Objective: To examine the relative efficacies of grief-focused cognitive behavior therapy and mindfulness-based cognitive therapy to reduce...